跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 2026-10-06AI 评分31

Leerink高级分析师下调Bristol Myers Squibb评级,因担忧其研发管线

Senior Leerink analyst downgrades Bristol Myers, citing pipeline fears

AI 导读

Leerink高级分析师下调Bristol Myers Squibb股票评级。该动作源于分析师对公司关键在研项目前景的怀疑。正文未提供具体管线药物名称或数据支持。

正文

A Leerink an­a­lyst is sig­nal­ing new bear­ish­ness in Bris­tol My­ers Squibb, down­grad­ing his view of the com­pa­ny’s stock be­cause of skep­ti­cism about some key up­com­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news